Skip to content
Contact
0

IDK

Home » IDK

Showing all 33 results

Certolizumab Drug Level ELISA (RUO) (IDKmonitor®)

Lab assay
The IDKmonitor Certolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free certolizumab therapeutic drug in serum and EDTA plasma samples. For research use only.

IDK® Anti-SARS-CoV-2 IgG (quantitative) ELISA

Lab assay
The IDK anti-SARS-CoV-2 quantitative IgG ELISA is for the specific detection and quantification of human IgG antibodies against the SARS-CoV-2 spike protein in serum and plasma samples.

IDK® Stool Sample Application System prefilled with IDKExtract®

Accessory
Stool samples can be extracted directly and efficiently using the IDK Stool Sample Application System, which allows easy, clean and precise preparation of stool sample extracts.

IDK® Stool Sample Application System

Accessory
Stool samples can be extracted directly and efficiently using the IDK Stool Sample Application System, which allows easy, clean and precise preparation of stool sample extracts.

IDK® TurbiTUBE®

Accessory
Stool samples can be extracted directly and efficiently using the IDK TurbiTUBE, which allows easy, clean and precise preparation of sample extracts ready for direct measurement using the IDK Turbi- range of assays.

Ustekinumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Ustekinumab is a fully humanised IgG1 therapeutic monoclonal antibody used for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. The IDKmonitor® Ustekinumab Free Anti-drug Antibody ELISA enables the reliable determination of free, unbound anti-ustekinumab antibodies in serum and plasma.

Ustekinumab Total Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Ustekinumab is a fully humanised IgG1 therapeutic monoclonal antibody used for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. This drug-tolerant assay enables the reliable determination of anti-drug antibodies even in the presence of ustekinumab. For research use only.

IDK® TurbiPEL®

Lab assay
The IDK TurbiPEL is a particle enhanced turbidimetric immunoassay (PETIA) that uses monoclonal antibodies for the determination of human pancreatic elastase in stool samples.

IDK® TurbiFIT®

Lab assay
The IDK TurbiFIT employs a particle-enhanced turbidimetric immunoassay (PETIA) methodology, utilising polyclonal antibodies to accurately quantify human haemoglobin levels in stool samples. The test can be applied to colorectal cancer screening of asymptomatic individuals as well as testing symptomatic patients for evidence or organic bowel disease.

IDK® TurbiCAL®

Lab assay
The IDK TurbiCAL is a particle enhanced turbidimetric immunoassay (PETIA) for the detection and quantification of human calprotectin (MRP 8/14; S100A8/A9) in stool samples. Based on a monoclonal antibody test system the test is intended for diagnosis and monitoring disease activity in inflammatory bowel disease (IBD).

IDK® Zonulin (Stool) ELISA

Lab assay
The IDK Zonulin (Stool) ELISA is a quantitative assay designed for the precise determination of zonulin levels in stool samples. Zonulin, a protein intricately involved in intestinal barrier function, triggers a cascade of events that results in epithelial tight junction disassembly in the intestine.

IDK® Zonulin (Serum) ELISA

Lab assay
The IDK Zonulin (Serum) ELISA is a quantitative assay for the determination of zonulin in serum. Zonulin is a protein that is involved in intestinal barrier function, regulating tight junctions and increasing intestinal epithelium permeability. It has been highlighted as a potential marker of “leaky gut” syndrome.

IDK® Pancreatic Elastase ELISA

Lab assay
The IDK Pancreatic Elastase ELISA is a quantitative enzyme immunoassay for the determination of pancreatic elastase in stool samples. This supports the diagnosis of exocrine pancreatic insufficiency in a range of cases including unexplained diarrhoea, gut microbiota dysbiosis, IBS/IBD, steatorrhoea, flatulence, weight loss, upper abdominal pain and dietary intolerances.

Helicobacter pylori Stool Antigen ELISA (IDK®)

Lab assay
The IDK Helicobacter pylori Stool Antigen ELISA is intended for the detection of H. pylori in stool samples. It can be used for confirmation of active H. pylori infection in the absence of atrophic gastritis, bleeding ulcer and use of proton pump inhibitors.

IDK® Faecal Lactoferrin ELISA

Lab assay
The IDK Fecal Lactoferrin ELISA is an enzyme immunoassay for the quantitative determination of lactoferrin – a well-established biomarker for neutrophilic intestinal inflammation – in stool samples. Faecal lactoferrin measurement supports monitoring of disease activity in inflammatory bowel disease (IBD), prediction of relapse of IBD and assessment of treatment response in IBD.

IDK® Faecal Calprotectin ELISA

Lab assay
The IDK Faecal Calprotectin ELISA is an enzyme immunoassay for the quantitative determination of human calprotectin (MRP 8/14; S100A8/A9) in stool samples, to rule out and monitor inflammatory bowel diseases (IBDs) non-invasively.

IDK® Faecal Bile Acids assay

Lab assay
The IDK Faecal Bile Acids assay allows quantitative determination of bile acids in stool samples. This rapid photometric assay can aid the diagnosis of bile acid diarrhoea in patients with diarrhoea-predominant irritable bowel syndrome (D-IBS) or chronic diarrhoea in patients who have undergone chloecystectomy or intestinal resection.

IDK® Faecal Haemoglobin ELISA

Lab assay
The IDK Fecal Haemoglobin (FIT) ELISA stands as a cutting-edge enzyme immunoassay designed to deliver precise quantitative measurements of human haemoglobin in stool samples. This assay serves as a crucial marker for identifying early colorectal cancer and adenomatous polyps by detecting gastrointestinal bleeding, particularly originating from colorectal adenomas and tumours.

Vedolizumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
The IDKmonitor Vedolizumab Free Anti-drug ELISA kit is a microplate-based sandwich ELISA for the determination of free anti-vedolizumab antibodies in plasma or serum samples. Detecting high levels of free anti-vedolizumab antibodies in patients when the drug level is low (undetectable or sub-therapeutic) may indicate poorer long-term outcomes and suggest the need to switch treatment.

Rituximab Drug Level ELISA (IDKmonitor®)

Lab assay
The IDKmonitor Rituximab Drug Level ELISA kit is a microplate-based quantitative assay for the determination of free rituximab from plasma or serum samples. Rituximab is a chimeric therapeutic monoclonal antibody (mAb) that targets B-cells (CD-20) in the treatment of rheumatoid arthritis, non-Hodgkin's B-cell lymphomas, lymphocytic leukaemia, active granulomatosis with polyangiitis and microscopic polyangiitis. For research use only.

Vedolizumab Drug Level ELISA (IDKmonitor®)

Lab assay
Vedolizumab is a recombinant protein used to treat Crohn's disease and ulcerative colitis. The IDKmonitor Vedolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free vedolizumab in plasma or serum samples.

Ustekinumab Drug Level ELISA (IDKmonitor®)

Lab assay
Ustekinumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Ustekinumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free ustekinumab in plasma or serum samples.

Infliximab Total Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Infliximab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug (both free- nd bound antibodies) in serum and plasma.

Infliximab Drug Level ELISA (IDKmonitor®)

Lab assay
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Infliximab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free infliximab in plasma or serum samples.

Golimumab Drug Level ELISA (IDKmonitor®)

Lab assay
Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Golimumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free golimumab in plasma or serum samples. For research use only.

Etanercept Free Anti-drug Antibody ELISA (RUO) (IDKmonitor®)

Lab assay
IDKmonitor Etanercept Free Anti-drug Antibody ELISA is an assay that detects human antibodies against etanercept in EDTA plasma and serum samples. Etanercept is a human therapeutic monoclonal antibody used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis. For research use only.

Etanercept Drug Level ELISA (RUO) (IDKmonitor®)

Lab assay
The IDKmonitor Etanercept Drug Level ELISA is a microplate-based assay that allows quantitative determination of free etanercept from plasma or serum samples. Etanercept is a human therapeutic monoclonal antibody (mAb) used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis. For research use only.

Adalimumab Total Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat chronic inflammatory diseases. This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug (free- and bound- anti-drug antibodies) in serum and plasma.

Adalimumab Drug Level ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat inflammatory bowel disease (IBD) and other chronic inflammatory conditions. The IDKmonitor Adalimumab Drug Level ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free adalimumab from plasma or serum samples.

Infliximab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation which is a major cause of loss of drug response. IDKmonitor Infliximab Free Anti-drug Antibody ELISA is an assay that detects human antibodies against infliximab in EDTA plasma and serum samples.

Golimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response.

Adalimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat chronic inflammatory diseases. This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Free Anti-drug antibody ELISA detects free (non-drug bound) antibodies to Adalimumab in serum and plasma.

IDK® Oncostatin M ELISA

Lab assay
The IDK Oncostatin M (OSM) ELISA is for the quantitative determination of oncostatin M in serum, plasma or stool samples. OSM and its receptor, OSMR, are involved in gut inflammation, and are upregulated in the mucosa of IBD patients.

Showing all 33 results